| Biomedical Applications of TiO2 Nanostructures: Recent Advances S Jafari, B Mahyad, H Hashemzadeh, S Janfaza, T Gholikhani, L Tayebi International journal of nanomedicine, 3447-3470, 2020 | 272 | 2020 |
| Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin S Khaledi, S Jafari, S Hamidi, O Molavi, S Davaran Journal of Biomaterials Science, Polymer Edition 31 (9), 1107-1126, 2020 | 70 | 2020 |
| Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer S Jafari, O Molavi, H Kahroba, MS Hejazi, N Maleki-Dizaji, S Barghi, ... Cellular and Molecular Life Sciences 77, 3693-3710, 2020 | 54 | 2020 |
| STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells S Jafari, A Lavasanifar, MS Hejazi, N Maleki-Dizaji, M Mesgari, O Molavi DARU Journal of Pharmaceutical Sciences, 1-11, 2020 | 40 | 2020 |
| Enhanced production of insulin-like growth factor I protein in Escherichia coli by optimization of five key factors J Ranjbari, V Babaeipour, H Vahidi, H Moghimi, MR Mofid, MM Namvaran, ... Iranian Journal of Pharmaceutical Research: IJPR 14 (3), 907, 2015 | 32 | 2015 |
| Recombinant production of mecasermin in E. coli expression system S Jafari, V Babaeipour, HAE Seyedi, M Rahaie, MR Mofid, L Haddad, ... Research in Pharmaceutical Sciences 9 (6), 453-461, 2014 | 28 | 2014 |
| Poly (ethylene glycol)-poly (ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin AH Rad, F Asiaee, S Jafari, A Shayanfar, A Lavasanifar, O Molavi BioImpacts, 2020 | 19 | 2020 |
| Isolation and Identification of Antibiotic-Producing Halophilic Bacteria from Dagh Biarjmand and Haj Aligholi Salt Deserts, Iran B Elyasifar, S Jafari, S Halajnezhadi, F Chapeland-Leclerc, ... Pharmaceutical Sciences 25 (1), 70-77, 2019 | 17 | 2019 |
| Renoprotective effects of prazosin on ischemia-reperfusion injury in rats MM Rahimi, A Bagheri, Y Bagheri, E Fathi, S Bagheri, AV Nia, S Jafari, ... Human & Experimental Toxicology 40 (8), 1263-1273, 2021 | 13 | 2021 |
| Recent clinical findings on the role of kinase inhibitors in COVID-19 management Z Malekinejad, A Baghbanzadeh, A Nakhlband, B Baradaran, S Jafari, ... Life Sciences, 120809, 2022 | 10 | 2022 |
| Chemical Compositions and Anti-Proliferative Activity of the Aerial Parts and Rhizomes of Squirting Cucumber, Cucurbitaceae O Molavi, F Torkzaban, S Jafari, S Asnaashari, P Asgharian Jundishapur Journal of Natural Pharmaceutical Products, 2019 | 10 | 2019 |
| Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines S Jafari, S Dabiri, E Mehdizadeh Aghdam, E Fathi, N Saeedi, ... Clinical and Translational Oncology 25 (8), 2559-2568, 2023 | 7 | 2023 |
| Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy S Jafari, S Heydarian, R Lai, EM Aghdam, O Molavi BioImpacts: BI 13 (1), 51, 2023 | 7 | 2023 |
| The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study S Montazersaheb, S Jafari, MD Aytemir, E Ahmadian, M Ardalan, M Zor, ... Molecular biology reports 50 (11), 9307-9314, 2023 | 6 | 2023 |
| Stearoylcholine and oleoylcholine: Synthesis, physico-chemical characterization, nanoparticle formation, and toxicity studies M Saadat, S Jafari, P Zakeri-Milani, J Shahbazi-Mojarrad, H Valizadeh Journal of Drug Delivery Science and Technology 59, 101872, 2020 | 5 | 2020 |
| Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds M Amiri, O Molavi, S Sabetkam, S Jafari, S Montazersaheb Cancer Cell International 23 (1), 200, 2023 | 3 | 2023 |
| Development of polymeric micelles loaded with STAT3 inhibitory, stattic, for cancer treatment H Masoumzadeh, N Hoseinzad, S Jafari, A Shayanfar, H Vaez, O Molavi Medical Journal of Tabriz University of Medical Sciences 43 (4), 335-345, 2021 | 3 | 2021 |
| Silibinin-loaded nanostructured lipid carriers for growth inhibition of cisplatin-resistant ovarian Cancer cells S Jafari, A Bakhshaei, M Eskandani, O Molavi ASSAY and Drug Development Technologies 20 (8), 339-348, 2022 | 2 | 2022 |
| Efficient Process Development for High‐level Production, Purification, Formulation, and Characterization of Recombinant Mecasermin in E. coli MR Mofid, V Babaeipour, S Jafari, L Haddad, S Moghim, J Ghanavi Biotechnology and Applied Biochemistry, 2020 | 2 | 2020 |
| Cloning and over-expression of recombinant human insulin–like growth factor-I in E. coli S Jafari, V Babaeipour, S Moghim, MR Mofid, M Rahaie, J Fallah Research in Pharmaceutical Sciences 7 (5), 417, 2012 | 2 | 2012 |
Ommoleila MolaviUniversity of Alberta-Tabriz University of Medical SciencesVerified email at ualberta.ca
